Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Polydex Pharmaceuticals Debt to Equity Ratio 2010-2023 | POLXF

Current and historical debt to equity ratio values for Polydex Pharmaceuticals (POLXF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Polydex Pharmaceuticals debt/equity for the three months ending April 30, 2023 was 0.00.
  
Polydex Pharmaceuticals Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-04-30 $0.00B $0.01B 0.24
2023-01-31 $0.00B $0.01B 0.17
2022-10-31 $0.00B $0.01B 0.24
2022-07-31 $0.00B $0.01B 0.11
2022-04-30 $0.00B $0.01B 0.24
2022-01-31 $0.00B $0.01B 0.21
2021-10-31 $0.00B $0.01B 0.17
2021-07-31 $0.00B $0.01B 0.15
2021-04-30 $0.00B $0.01B 0.18
2021-01-31 $0.00B $0.01B 0.20
2020-10-31 $0.00B $0.01B 0.24
2020-07-31 $0.00B $0.01B 0.19
2020-04-30 $0.00B $0.01B 0.21
2020-01-31 $0.00B $0.01B 0.20
2019-10-31 $0.00B $0.01B 0.25
2019-07-31 $0.00B $0.01B 0.25
2019-04-30 $0.00B $0.01B 0.26
2019-01-31 $0.00B $0.01B 0.23
2018-10-31 $0.00B $0.01B 0.26
2018-07-31 $0.00B $0.01B 0.28
2018-04-30 $0.00B $0.01B 0.28
2018-01-31 $0.00B $0.01B 0.27
2017-10-31 $0.00B $0.01B 0.25
2017-07-31 $0.00B $0.01B 0.25
2017-04-30 $0.00B $0.01B 0.38
2017-01-31 $0.00B 0.00
2016-10-31 $0.00B $0.01B 0.41
2016-07-31 $0.00B $0.01B 0.40
2016-04-30 $0.00B $0.00B 0.00
2016-01-31 $0.00B $0.00B 0.46
2015-10-31 $0.00B $0.00B 0.47
2015-07-31 $0.00B $0.00B 0.63
2015-04-30 $0.00B $0.00B 0.68
2015-01-31 $0.00B $0.00B 0.79
2014-10-31 $0.00B $0.00B 0.85
2014-07-31 $0.00B $0.00B 0.83
2014-04-30 $0.00B $0.00B 0.80
2014-01-31 $0.00B $0.00B 0.84
2013-10-31 $0.00B $0.00B 0.86
2013-07-31 $0.00B $0.00B 0.92
2013-04-30 $0.00B $0.00B 0.82
2013-01-31 $0.00B $0.00B 0.91
2012-10-31 $0.00B $0.00B 0.94
2012-07-31 $0.00B $0.00B 0.76
2012-04-30 $0.00B $0.00B 0.75
2012-01-31 $0.00B $0.00B 0.69
2011-10-31 $0.00B $0.00B 0.80
2011-04-30 $0.00B $0.00B 0.82
2011-01-31 $0.00B $0.00B 0.86
2010-10-31 $0.00B $0.00B 0.81
2010-07-31 $0.00B $0.00B 0.73
2010-04-30 $0.00B $0.00B 0.61
2010-01-31 $0.00B $0.00B 0.65
2009-10-31 $0.00B $0.01B 0.51
2009-07-31 $0.00B $0.01B 0.47
2009-04-30 $0.00B $0.01B 0.37
2009-01-31 $0.00B $0.01B 0.31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.004B
Polydex Pharmaceuticals Limited develops and manufactures biotechnology-based products serving markets primarily across North America and globally. The Company primarily focuses on the manufacture and development of Dextran and derivative products. Its product is marketed in human pharmaceutical market and bulk pharmaceutical intermediates for the worldwide pharmaceutical industry. The company was formerly known as Polydex Chemicals Limited and changed its name to Polydex Pharmaceuticals Limited. Polydex Pharmaceuticals Limited is based in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.981B 31.71
Chugai Pharmaceutical (CHGCY) Japan $49.415B 22.09
Takeda Pharmaceutical (TAK) Japan $41.206B 8.35
Merck (MKGAF) Germany $24.305B 23.57
Astellas Pharma (ALPMY) Japan $17.843B 28.17
Sandoz Group AG (SDZNY) Switzerland $15.171B 0.00
Neurocrine Biosciences (NBIX) United States $14.141B 38.71
Shionogi (SGIOY) Japan $12.740B 11.07
United Therapeutics (UTHR) United States $12.264B 13.07
Catalent (CTLT) United States $9.891B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.585B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.552B 7.20
Revolution Medicines (RVMD) United States $6.291B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.547B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.005B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.835B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.064B 0.00
Summit Therapeutics (SMMT) United States $3.033B 0.00
Corcept Therapeutics (CORT) United States $2.898B 26.26
PTC Therapeutics (PTCT) United States $2.848B 0.00
Dyne Therapeutics (DYN) United States $2.731B 0.00
Indivior (INDV) United States $2.305B 10.93
Recursion Pharmaceuticals (RXRX) United States $2.146B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.988B 11.30
Catalyst Pharmaceuticals (CPRX) United States $1.880B 18.30
Fusion Pharmaceuticals (FUSN) Canada $1.829B 0.00
Evotec AG (EVO) Germany $1.747B 0.00
Ardelyx (ARDX) United States $1.731B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.719B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.607B 24.15
Avadel Pharmaceuticals (AVDL) Ireland $1.501B 0.00
Xencor (XNCR) United States $1.464B 0.00
Pacira BioSciences (PCRX) United States $1.411B 13.42
Soleno Therapeutics (SLNO) United States $1.376B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.306B 0.00
4D Molecular Therapeutics (FDMT) United States $1.300B 0.00
Collegium Pharmaceutical (COLL) United States $1.106B 6.62
Enliven Therapeutics (ELVN) United States $1.081B 0.00
Cassava Sciences (SAVA) United States $1.046B 0.00
Cronos Group (CRON) Canada $1.009B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.949B 14.78
Relay Therapeutics (RLAY) United States $0.927B 0.00
USANA Health Sciences (USNA) United States $0.911B 14.90
Ocular Therapeutix (OCUL) United States $0.898B 0.00
ARS Pharmaceuticals (SPRY) United States $0.853B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.839B 0.00
ProKidney (PROK) United States $0.805B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.748B 0.00
Lyell Immunopharma (LYEL) United States $0.691B 0.00
Sage Therapeutics (SAGE) United States $0.681B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.678B 0.00
Silence Therapeutics (SLN) United Kingdom $0.658B 0.00
Harrow (HROW) United States $0.619B 0.00
Savara (SVRA) United States $0.576B 0.00
Exscientia (EXAI) United Kingdom $0.572B 0.00
Siga Technologies (SIGA) United States $0.530B 6.77
Altimmune (ALT) United States $0.524B 0.00
Heron Therapeutics (HRTX) United States $0.523B 0.00
Lexeo Therapeutics (LXEO) United States $0.510B 0.00
OmniAb (OABI) United States $0.505B 0.00
Bioventus (BVS) United States $0.501B 19.18
Larimar Therapeutics (LRMR) United States $0.477B 0.00
KalVista Pharmaceuticals (KALV) United States $0.476B 0.00
Verve Therapeutics (VERV) United States $0.448B 0.00
Korro Bio (KRRO) United States $0.446B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Esperion Therapeutics (ESPR) United States $0.426B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.416B 0.00
Fractyl Health (GUTS) United States $0.362B 0.00
Organogenesis (ORGO) United States $0.357B 67.25
Verrica Pharmaceuticals (VRCA) United States $0.354B 0.00
Tourmaline Bio (TRML) United States $0.350B 0.00
Nanobiotix S.A (NBTX) France $0.312B 0.00
Nektar Therapeutics (NKTR) United States $0.305B 0.00
Xeris Biopharma Holdings (XERS) United States $0.289B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 18.33
Aquestive Therapeutics (AQST) United States $0.279B 0.00
ESSA Pharma (EPIX) Canada $0.279B 0.00
Black Diamond Therapeutics (BDTX) United States $0.267B 0.00
Century Therapeutics (IPSC) United States $0.258B 0.00
Foghorn Therapeutics (FHTX) United States $0.256B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.256B 0.00
Acrivon Therapeutics (ACRV) United States $0.250B 0.00
Metagenomi (MGX) United States $0.249B 0.00
CytoDyn (CYDY) United States $0.235B 0.00
Akebia Therapeutics (AKBA) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.225B 0.00
Pyxis Oncology (PYXS) United States $0.225B 0.00
Prelude Therapeutics (PRLD) United States $0.222B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Eliem Therapeutics (ELYM) United States $0.216B 0.00
Avita Medical (RCEL) United States $0.212B 0.00
Galectin Therapeutics (GALT) United States $0.190B 0.00
Zevra Therapeutics (ZVRA) United States $0.188B 0.00
Adherex Technologies (FENC) United States $0.188B 229.00
Telomir Pharmaceuticals (TELO) United States $0.187B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Elite Pharmaceuticals (ELTP) United States $0.181B 16.90
Innate Pharma SA (IPHYF) France $0.176B 0.00
Incannex Healthcare (IXHL) Australia $0.171B 0.00
MediWound (MDWD) Israel $0.161B 0.00
VAXART, INC (VXRT) United States $0.159B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.158B 0.00
Cardiol Therapeutics (CRDL) Canada $0.152B 0.00
Context Therapeutics (CNTX) United States $0.146B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
OptiNose (OPTN) United States $0.128B 0.00
FibroGen (FGEN) United States $0.127B 0.00
Regulus Therapeutics (RGLS) United States $0.126B 0.00
Citius Pharmaceuticals (CTXR) United States $0.124B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.121B 8.09
PMV Pharmaceuticals (PMVP) United States $0.104B 0.00
ProPhase Labs (PRPH) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
Relmada Therapeutics (RLMD) United States $0.094B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
SCYNEXIS (SCYX) United States $0.085B 1.19
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
Protara Therapeutics (TARA) United States $0.057B 0.00
Carisma Therapeutics (CARM) United States $0.052B 0.00
Nutriband (NTRB) United States $0.052B 0.00
Inotiv (NOTV) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.048B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.043B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
DURECT (DRRX) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Lipocine (LPCN) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.029B 0.00
BioVie (BIVI) United States $0.028B 0.00
JanOne (JAN) United States $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.80
Aptorum Group (APM) United Kingdom $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
Lyra Therapeutics (LYRA) United States $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Mannatech (MTEX) United States $0.014B 0.00
CERo Therapeutics Holdings (CERO) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
SHINECO (SISI) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.02
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.15